Your session is about to expire
← Back to Search
Home-Based Exercise for Cancer Patients
N/A
Recruiting
Led By Christina Dieli-Conwright, PhD, MPH
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Newly diagnosed with stage I-III breast, colorectal or prostate cancer
Over 18 years old; children under the age of 18 will be excluded due to rarity of disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up evaluated at months 2 and 4
Awards & highlights
Study Summary
This trial will test whether a 16-week, home-based, aerobic and resistance exercise intervention will increase physical activity levels in Black and Hispanic breast, colorectal, or prostate cancer patients.
Who is the study for?
This trial is for Black and Hispanic adults over 18 with stage I-III breast, colorectal, or prostate cancer who are overweight/obese. They must be starting chemotherapy soon, speak English/Spanish, do less than 90 minutes of exercise per week, and can visit Dana-Farber Cancer Institute for data collection.Check my eligibility
What is being tested?
The THRIVE Study tests if a 16-week home-based exercise program (either supervised via Zoom or unsupervised) improves physical activity in minority cancer patients compared to a control group doing stretching exercises.See study design
What are the potential side effects?
Potential side effects from the exercise programs may include typical risks associated with physical activity such as muscle strains or sprains. However, these activities are designed considering participants' health status.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been recently diagnosed with early to mid-stage breast, colorectal, or prostate cancer.
Select...
I am over 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ evaluated at months 2 and 4
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~evaluated at months 2 and 4
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Physical Activity Participation
Secondary outcome measures
Acceptability of Intervention Questionnaire Ratings
Augmentation Index
Biomarkers for Cardiovascular and Metabolic Health - HbA1c
+16 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Unsupervised aerobic and resistance exercise (UNSUP)Experimental Treatment1 Intervention
Participants will be randomly assigned to receive 3x weekly at home, unsupervised aerobic and resistance exercise sessions with a 1x weekly telehealth call with a certified exercise trainer for 16 weeks.
Participants will also have a baseline test, mid intervention cardiovascular and strength tests and one postintervention and one follow up visit.
Group II: Supervised aerobic and resistance exercise (SUP)Experimental Treatment1 Intervention
Participants will be randomly assigned to receive 3x weekly at home, virtually supervised aerobic and resistance exercise sessions with a certified exercise trainer for 16 weeks.
Participants will also have a baseline test, mid intervention cardiovascular and strength tests and one postintervention and one follow up visit.
Group III: Attention Control (AC)Active Control1 Intervention
Participants will be randomly assigned to receive 3x weekly at home stretching exercise for 16 weeks.
Participants will also have a baseline test, mid intervention cardiovascular and strength tests and one postintervention and one follow up visit.
Find a Location
Who is running the clinical trial?
University of Massachusetts, BostonOTHER
34 Previous Clinical Trials
15,467 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,690 Previous Clinical Trials
40,930,386 Total Patients Enrolled
Dana-Farber Cancer InstituteLead Sponsor
1,080 Previous Clinical Trials
340,938 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are required to do structured exercise for more than 90 minutes per week.I started chemotherapy less than 4 weeks ago.I do not have any uncontrolled illnesses like infections or diabetes.You are overweight or obese, which means you have too much body fat.I have a condition affecting my muscles, bones, heart, or lungs.I have been recently diagnosed with early to mid-stage breast, colorectal, or prostate cancer.My cancer has spread to other parts of my body.You identify yourself as Hispanic or Black.I am over 18 years old.I speak English or Spanish.I have another active cancer besides the one being treated.You are not physically active and do not exercise for at least 90 minutes per week.
Research Study Groups:
This trial has the following groups:- Group 1: Unsupervised aerobic and resistance exercise (UNSUP)
- Group 2: Supervised aerobic and resistance exercise (SUP)
- Group 3: Attention Control (AC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there openings for participants in this experimental research?
"According to details posted on clinicaltrials.gov, this medical trial is recruiting participants as of November 14th 2022; the original post was shared on October 31st 2022."
Answered by AI
How many individuals are being monitored as part of this research project?
"Affirmative. Per the information available on clinicaltrials.gov, this research is actively looking for participants and was last modified on 11/14/2022; it had been posted initially on 10/31/2022. Currently, 135 volunteers need to be sourced from 2 different medical sites."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger